Amesite Inc

Amesite Inc(AMST)の株式分析

$0.515

-0.021 (-4.15%)終値時点

Loading chart…
高値
0.537
始値
0.537
出来高加重平均価格
0.52
出来高
24.47K
時価総額
7.04M
安値
0.515
売買代金
12.79K
EV/EBITDA(TTM)
0.00

Amesite Inc. is a technology company. The Company focused on building and commercializing AI-powered solutions for the healthcare sector. The Company specializes in the development and marketing of business-to-consumer (B2C) and business-to-business (B2B) artificial intelligence (AI)-driven solutions, including its higher ed platform that offers professional learning. The Company's platform utilizes infrastructure to deliver both Amesite Engage for higher education and NurseMagic for healthcare. NurseMagic is a mobile app for healthcare professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations. NurseMagic is designed for use across various healthcare modalities, such as skilled nursing, assisted living, memory care, home health, and rehabilitation centers.

amesite.com

AI分析 of Amesite Inc (AMST)

売り

Amesite Inc is not a good buy right now due to its extremely low Relative Strength Index (RSI) of 11.041, indicating it is oversold, and a staggering year-to-date change of -74.25%, reflecting significant declines in its stock price. The company's financials show consistent net losses, with the latest EPS reported at -0.14 and a forward P/E ratio of 0, suggesting no expected profitability in the near future. The main risk is the substantial decline in stock value, with a 52-week low of 0.52, which indicates a lack of investor confidence and potential for further losses.

バリュエーション指標

Amesite Inc(AMST)の現在の予想PERは0.00で、5年平均は-2.94です。

予想PER

適正
5年平均 P/E
-2.94
現在のP/E
0.00
割高
5.76
割安
-11.63

予想EV/EBITDA

適正
5年平均 EV/EBITDA
-3.91
現在のEV/EBITDA
0.00
割高
17.01
割安
-24.83

予想PSR

適正
5年平均 P/S
1.59
現在のP/S
0.00
割高
4.22
割安
-1.04

イベントタイムライン

2026-09-24 (ET)

07:00:00

Amesite Launches New Sales Model, NurseMagic Enterprise Priced at $1,099 per Month

2026-05-12 (ET)

17:30:00

Amesite Files Prospectus for Resale of 4.84M Shares

2026-04-27 (ET)

12:40:00

Amesite Issues 696,866 Shares at $1.435 Each

11:20:00

X-energy and Yesway Show Strong Debut Performance

09:40:00

Amesite Files for Withdrawal of S-1 Registration Statement

ニュース

AMST のよくある質問 — Alphio AI が回答

Amesite Inc. is a technology company. The Company focused on building and commercializing AI-powered solutions for the healthcare sector. The Company specializes in the development and marketing of business-to-consumer (B2C) and business-to-business (B2B) artificial intelligence (AI)-driven solutions, including its higher ed platform that offers professional learning. The Company's platform utilizes infrastructure to deliver both Amesite Engage for higher education and NurseMagic for healthcare. NurseMagic is a mobile app for healthcare professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations. NurseMagic is designed for use across various healthcare modalities, such as skilled nursing, assisted living, memory care, home health, and rehabilitation centers. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).

Amesite Inc is not a good buy right now due to its extremely low Relative Strength Index (RSI) of 11.041, indicating it is oversold, and a staggering year-to-date change of -74.25%, reflecting significant declines in its stock price. The company's financials show consistent net losses, with the latest EPS reported at -0.14 and a forward P/E ratio of 0, suggesting no expected profitability in the near future. The main risk is the substantial decline in stock value, with a 52-week low of 0.52, which indicates a lack of investor confidence and potential for further losses.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める